The European Commission has approved Givlaari (givosiran) to treat acute hepatic porphyria in patients, 12 and older,…
Articles by Marisa Wexler, MS
Regular removal of blood, through a procedure called phlebotomy, reduced symptoms and porphyrin levels in a person with…
Isoniazid, an antibiotic to treat tuberculosis, produces promising results in mice with erythropoietic protoporphyria (EPP), but the standard…
Alnylam Pharmaceuticals and Ironwood Pharmaceuticals are joining forces to better inform healthcare professionals about givosiran, Alnylam’s potential therapeutic for…
Forty previously unreported mutations in the HMBSÂ gene have been identified and found to be associated with the…
A case involving a patient with erythropoietic protoporphyria (EPP) accompanied by liver damage highlights the need for increased awareness of…